|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Accounts receivable | |||||||||
| Nonrelated Party | |||||||||
| Related Party | |||||||||
| Prepaid expenses | |||||||||
| Inventory | |||||||||
| Commodity derivative assets, current | |||||||||
| Asset held for sale | |||||||||
| Other current assets | |||||||||
| Total current assets | |||||||||
| Developed properties | |||||||||
| Undeveloped properties | |||||||||
| Midstream assets | |||||||||
| Accumulated depreciation, depletion, and amortization | |||||||||
| Natural gas properties, net | |||||||||
| Other property, plant, and equipment, net | |||||||||
| Deposits | |||||||||
| Goodwill | |||||||||
| Investment in BKV-BPP Power | |||||||||
| Commodity derivative assets | |||||||||
| Other noncurrent assets | |||||||||
| Total assets | |||||||||
| Liabilities, mezzanine equity, and equity | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued liabilities | |||||||||
| Contingent consideration payable | |||||||||
| Commodity derivative liabilities, current | |||||||||
| Income taxes payable to related party | |||||||||
| Credit facilities | |||||||||
| Payable to BPPUS for the BKV-BPP Power Joint Venture Transaction | |||||||||
| Current portion of Temple I Loan Agreements | |||||||||
| Current portion of long-term debt, net | |||||||||
| Current portion of Temple I Loan Agreements and Current portion of Long-term debt, net | |||||||||
| Notes Payable | |||||||||
| Total current portion of Temple I Loan Agreements and Current portion of Long-term debt, net | |||||||||
| Other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Asset retirement obligations | |||||||||
| Contingent consideration | |||||||||
| Commodity derivative liabilities | |||||||||
| Note payable to related party | |||||||||
| Temple I Loan Agreements and Long-term debt, net | |||||||||
| Deferred tax liability, net | |||||||||
| Other noncurrent liabilities | |||||||||
| Total liabilities | |||||||||
| Mezzanine equity | |||||||||
| Common stock, minority ownership puttable shares | |||||||||
| Equity-based compensation | |||||||||
| Total mezzanine equity | |||||||||
| Noncontrolling interest | |||||||||
| Stockholders’ equity | |||||||||
| Common stock, $0.01 par value; 500,000 authorized shares; 107,992 and 96,872 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Treasury stock, shares at cost; 214 shares as of September 30, 2026 and December 31, 2025 | |||||||||
| Additional paid-in capital | |||||||||
| Retained earnings | |||||||||
| Total stockholders’ equity | |||||||||
| Noncontrolling interest | |||||||||
| Total equity | |||||||||
| Total liabilities, mezzanine equity, and equity | |||||||||
| Treasury stock, at cost (in shares) |
Loading...